Published in Boll Soc Ital Biol Sper on August 15, 1979
Proposed diagnostic criteria for neurocysticercosis. Neurology (2001) 9.15
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut (2006) 9.03
Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol (2001) 4.46
Neurocysticercosis in an Orthodox Jewish community in New York City. N Engl J Med (1992) 3.86
Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution. Gastroenterology (1990) 3.61
Persistent hepatitis C viraemia without liver disease. Lancet (1993) 3.14
Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut (2008) 2.79
A population study on the prevalence of gallstone disease: the Sirmione Study. Hepatology (1987) 2.54
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther (2009) 2.41
Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis. Arch Intern Med (1997) 2.33
Endoscopic demonstration of loss of duodenal folds in the diagnosis of celiac disease. N Engl J Med (1988) 2.27
One-day therapy for treatment of Helicobacter pylori infection. Dig Dis Sci (1993) 2.27
Diet and gallstones in Italy: the cross-sectional MICOL results. Hepatology (1998) 2.21
Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease. Dig Dis Sci (1989) 2.17
Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.) Am J Epidemiol (1995) 2.09
An inter- and intra-laboratory comparison of breath ¹³CO₂analysis. Aliment Pharmacol Ther (2003) 2.03
Acquired gallstone opacification during cholelitholytic treatment with chenodeoxyholic, ursodeoxycholic, and tauroursodeoxycholic acids. Am J Gastroenterol (1995) 1.98
The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab (1993) 1.94
Enzymatic determination of cholesterol in bile. Clin Chim Acta (1975) 1.88
The risk of adenomatous polyps in asymptomatic first-degree relatives of persons with colon cancer. Gastroenterology (1995) 1.88
Prevalence of spontaneous hepatofugal portal flow in liver cirrhosis. Clinical and endoscopic correlation in 228 patients. Gastroenterology (1991) 1.82
Gallstone recurrence after successful oral bile acid treatment. A 12-year follow-up study and evaluation of long-term postdissolution treatment. Gastroenterology (1989) 1.81
Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. J Gastrointestin Liver Dis (2011) 1.80
Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. J Hepatol (1996) 1.79
Potential eradicability of taeniasis and cysticercosis. Bull Pan Am Health Organ (1993) 1.78
Effect of meal on portal hemodynamics in healthy humans and in patients with chronic liver disease. Hepatology (1989) 1.70
The influence of bile salt structure on self-association in aqueous solutions. J Biol Chem (1983) 1.62
Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes Rev (2004) 1.62
13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther (2003) 1.60
Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration. Aliment Pharmacol Ther (1994) 1.59
Physicochemical properties of bile acids and their relationship to biological properties: an overview of the problem. J Lipid Res (1984) 1.59
A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology (1994) 1.53
Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial. Am J Gastroenterol (1999) 1.52
Management of intrahepatic cholestasis in pregnancy. Lancet (1992) 1.44
A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy. Hepatology (1989) 1.43
Cost-effectiveness of different diagnostic strategies to assess gastro-oesophageal reflux disease in patients with unexplained chronic persistent cough in Italy. Dig Liver Dis (2006) 1.42
HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome. Hepatol Int (2014) 1.41
Re: Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst (1996) 1.41
Diabetic retinopathy in chronic pancreatitis. Gastroenterology (1990) 1.41
Fasting and postprandial gastrointestinal motility in ulcer and non-ulcer dyspepsia. Gut (1992) 1.38
Lipid, lipoprotein, and apolipoprotein assessment during an 8-wk very-low-calorie diet. Am J Clin Nutr (1992) 1.37
Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study. Ann Oncol (2005) 1.37
Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology (1997) 1.36
Assessment of portal hypertension by endoscopic ultrasonography. Gastrointest Endosc (1990) 1.34
Acid gastroesophageal reflux and symptom occurrence. Analysis of some factors influencing their association. Dig Dis Sci (1989) 1.30
Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther (2007) 1.29
Can early precut implementation reduce endoscopic retrograde cholangiopancreatography-related complication risk? Meta-analysis of randomized controlled trials. Endoscopy (2010) 1.29
Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab (1989) 1.29
The medical treatment of cholesterol gallstones: experience with chenodeoxycholic acid. Digestion (1976) 1.29
Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group. Aliment Pharmacol Ther (1997) 1.25
US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology (1986) 1.25
Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut (1994) 1.22
Community-based epidemiological investigations of cysticercosis due to Taenia solium: comparison of serological screening tests and clinical findings in two populations in Mexico. Clin Infect Dis (1994) 1.22
Liver cirrhosis: changes of Doppler waveform of hepatic veins. Radiology (1991) 1.20
Omeprazole, Helicobacter pylori, gastritis, and duodenal ulcer. Lancet (1989) 1.19
Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas. Int J Colorectal Dis (2007) 1.18
Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance. Gut (2003) 1.17
Neurological symptoms in occult neurocysticercosis after single taeniacidal dose of praziquantel. Lancet (1993) 1.16
Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose. Osteoarthritis Cartilage (2007) 1.16
Diagnostic value of serum primary bile acids in detecting bile acid malabsorption. Gut (1982) 1.16